Abstract:Detecting and mapping metabolism in tissues represents a major step in detecting, characterizing, treating and understanding cancers. Recently introduced deuterium metabolic imaging techniques could offer a noninvasive route for the metabolic imaging of animals and humans, based on using 2H magnetic resonance spectroscopic imaging (MRSI) to detect the uptake of deuterated glucose and the fate of its metabolic products. In this study, 2H6,6′-glucose was administered to mice cohorts that had been orthotopically implanted with two different models of pancreatic ductal adenocarcinoma (PDAC), involving PAN-02 and KPC cell lines. As the tumors grew, 2H6,6′-glucose was administered as bolii into the animals' tail veins, and 2H MRSI images were recorded at 15.2 T. 2D phase-encoded chemical shift imaging experiments could detect a signal from this deuterated glucose immediately after the bolus injection for both the PDAC models, reaching a maximum in the animals' tumors ~ 20 min following administration, and nearly total decay after ~ 40 min. The main metabolic reporter of the cancers was the 2H3,3′-lactate signal, which MRSI could detect and localize on the tumors when these were 5 mm or more in diameter. Lactate production time traces varied slightly with the animal and tumor model, but in general lactate peaked at times of 60 min or longer following injection, reaching concentrations that were ~ 10-fold lower than those of the initial glucose injection. This 2H3,3′-lactate signal was only visible inside the tumors. 2H-water could also be detected as deuterated glucose's metabolic product, increasing throughout the entire time course of the experiment from its ≈10 mM natural abundance background. This water resonance could be imaged throughout the entire abdomen of the animals, including an enhanced presence in the tumor, but also in other organs like the kidney and bladder. These results suggest that deuterium MRSI may serve as a robust, minimally invasive tool for the monitoring of metabolic activity in pancreatic tumors, capable of undergoing clinical translation and supporting decisions concerning treatment strategies. Comparisons with in vivo metabolic MRI experiments that have been carried out in other animal models are presented and their differences/similarities are discussed.

Spectral tracing of deuterium for imaging glucose metabolism

Vibrational Imaging of Glucose Uptake in Live Cells and Tissues by Stimulated Raman Scattering Microscopy

Mapping Metabolic Changes by Noninvasive, Multiparametric, High-Resolution Imaging Using Endogenous Contrast.

Review of a New Molecular Imaging Method——Deuterium Metabolic Spectroscopy and Imaging

Vibrational imaging of glucose uptake activity in live cells and tissues by stimulated Raman scattering microscopy(Conference Presentation)

Two-color vibrational imaging of glucose metabolism using stimulated Raman scattering.

Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models

Simultaneous dynamic glucose-enhanced (DGE) MRI and fiber photometry measurements of glucose in the healthy mouse brain

Metabolic Imaging with Deuterium Labeled Substrates.

Dynamic Glucose Enhanced Imaging using Direct Water Saturation

In-vivo tracking of deuterium metabolism in mouse organs using LC-MS/MS

A pre-targeting strategy for imaging glucose metabolism using technetium-99m labelled dibenzocyclooctyne derivative.

Whole‐brain deuterium metabolic imaging via concentric ring trajectory readout enables assessment of regional variations in neuronal glucose metabolism

Optical Imaging of Metabolic Dynamics in Animals

Molecular imaging of tumor metabolism: Insight from pyruvate- and glucose-based deuterium MRI studies

Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy

Deuterium Metabolic Imaging Phenotypes Mouse Glioblastoma Heterogeneity Through Glucose Turnover Kinetics

Deuterium metabolic imaging of the human abdomen at clinical field strength

Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi‐echo bSSFP: A pancreatic cancer investigation

Exogenous detection of 13C-glucose metabolism in tumor and diet-induced obesity models

Fast and Quantitative T1ρ-weighted Dynamic Glucose Enhanced MRI